日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evolution of preclinical characterization and insights into clinical pharmacology of checkpoint inhibitors approved for cancer immunotherapy

获批用于癌症免疫治疗的检查点抑制剂的临床前表征进展及临床药理学见解

Sreeneeranj Kasichayanula #, Sandhya Mandlekar #, Vittal Shivva, Maulik Patel, Sandhya Girish

Discovery of disubstituted cyclohexanes as a new class of CC chemokine receptor 2 antagonists

发现双取代环己烷作为一类新型 CC 趋化因子受体 2 拮抗剂

Robert J Cherney, Ruowei Mo, Dayton T Meyer, David J Nelson, Yvonne C Lo, Gengjie Yang, Peggy A Scherle, Sandhya Mandlekar, Zelda R Wasserman, Heather Jezak, Kimberly A Solomon, Andrew J Tebben, Percy H Carter, Carl P Decicco